Objective: Thrombomodulin is a multidomain receptor primarily expressed by vascular endothelium. The lectin-like domain of thrombomodulin has anti-inflammatory properties. In this study, we investigated the role of the thrombomodulin lectin-like domain in the host response to Gram-negative sepsis caused by Burkholderia pseudomallei, a "Tier 1" biothreat agent and the caus-ative agent of melioidosis, a common form of community-acquired sepsis in Southeast Asia. Design: Animal study. Setting: University research laboratory. Subjects: Wild-type mice and mice lacking the lectin-like domain of thrombomodulin. Interventions: Mice were intranasally infected with live B. pseudomallei and killed after 24, 48, or 72 hours for harvesting of lungs, liver, spleen, and blood. Additionally, survival studies were performed. Measurements and Main Results: Following exposure to B. pseudomallei, mice lacking the lectin-like domain of thrombomodulin showed a survival advantage, accompanied by decreased bacterial loads in the blood, lungs, liver, and spleen. Although lung histopathology did not differ between groups, mice lacking the lectin-like domain of thrombomodulin displayed strongly attenuated systemic inflammation, as reflected by lower plasma cytokine levels, maintenance of normal kidney and liver function, histologic evidence of reduced organ damage, and damage to the spleen. Conclusions: This study reveals for the first time a detrimental role for the thrombomodulin lectin-like domain in the host response to sepsis caused by a clinically relevant Gram-negative pathogen. (Crit Care Med 2014; 42:e221-e230) 
interactions, TM modulates inflammation, coagulant and fibrinolysis, and cell proliferation.
TM consists of five structural domains: the N-terminal C-type lectin-like domain, six epidermal growth factor (EGF)-like repeats (EGF domain), a serine/threonine-rich domain, a transmembrane domain, and a cytoplasmic domain (2) . The EGF domain is required for thrombin-mediated generation of activated PC (APC), which has anticoagulant and cytoprotective functions (10) , and thrombin-mediated generation of activated TAFI, which has both antifibrinolytic and complement factor (C)3a-and C5a-degrading properties (4, 6) . In contrast to the EGF domain, the lectin-like domain lacks anticoagulant and antifibrinolytic properties (11) . Instead, this domain of TM, with homology to C-type lectins, plays a major role in the regulation of inflammation, complement activation, cell adhesion, and cell proliferation (2, 6, 12) . As compared with wild-type (WT) mice, mice lacking the TM lectin-like domain (TM LeD/LeD mice) exhibited reduced survival after a systemic lipopolysaccharide (LPS) challenge and increased accumulation of polymorphonuclear neutrophils in their lungs (11) . These effects may be caused by specific interaction of the lectin-like domain of TM with Lewis Y antigen of LPS (7, 8) . The lectin-like domain of TM also displayed anti-inflammatory properties in models of myocardial ischemia-reperfusion injury (13) , acute inflammatory arthritis (6) , shiga toxininduced hemolytic uremic syndrome (HUS) (14) , diabetic glomerulopathy (15) , and allergic lung inflammation (16) . Recently, administration of recombinant lectin-like domain of TM was shown to be protective in Klebsiella pneumoniainduced sepsis (7) . In contrast to the preceding compelling observations, lack of the lectin-like domain of TM was beneficial in the host response to pneumonia caused by the Gram-positive bacterium Streptococcus pneumoniae. Indeed, infected TM LeD/LeD mice had a significant survival advantage, lower bacterial loads, and less pulmonary inflammation as compared with WT mice (17) .
In spite of the protection afforded by soluble TM lectin-like domain in K. pneumonia-induced sepsis, our understanding of the role of the lectin-like domain of TM during Gram-negative sepsis is limited. This is of particular interest, given that there are reportedly direct interactions between the TM lectin-like domain and LPS, the proinflammatory component of the Gram-negative cell wall (7, 8) . Furthermore, delineating the mechanisms by which the lectin-like domain of TM regulates the host response to various pathogens may lead to novel therapies. In this study, we sought to characterize the role of the lectin-like domain of TM during melioidosis, an infectious disease caused by the Gram-negative bacillus Burkholderia pseudomallei. Melioidosis is characterized by a wide array of systemic symptoms and signs with fever and pain and involvement of essentially any organ, but primarily the lungs, skin, and joints (18) (19) (20) . In Southeast Asia and Northern Australia where it is endemic and an important cause of community-acquired sepsis, infection with melioidosis may be associated with mortalities up to 40% despite appropriate antibiotic therapy (18) (19) (20) . Indeed, B. pseudomallei was recently classified as a "Tier 1" disease agent considered to be an exceptional threat to security (21) . Interestingly, previous data showed marked up-regulation of TM in culture-proven melioidosis patients when compared with healthy controls (22) , prompting us to evaluate whether this association has pathophysiologic relevance. In this study, we investigated the role of the lectin-like domain of TM by comparing WT mice with TM LeD/LeD mice after intranasal challenge with B. pseudomallei.
MATERIALS AND METHODS

Mice
Pathogen-free 10-week-old male WT C57BL/6 mice were purchased from Charles River (Maastricht, the Netherlands). TM LeD/LeD mice were generated as described (11) and backcrossed at least eight times to a C57BL/6 genetic background. Deficiency of the TM lectin-like domain was confirmed by polymerase chain reaction of lysed toes of newborn TM LeD/LeD mice. TM LeD/LeD mice express normal antigenic levels of TM, and thrombin-mediated activation of PC is intact and unaffected by the lack of the lectin-like domain (11) . In addition, activation of TAFI is also unaffected as for this process not the lectin-like domain but the EGF-like repeats of TM are involved (2) . Mice were maintained at the animal care facility of the Academic Medical Center (University of Amsterdam), according to national guidelines with free access to food and water. The Committee on Use and Care of Animals of the University of Amsterdam approved all experiments.
Experimental Infection and Determination of Bacterial Growth
Experimental melioidosis was induced by intranasal inoculation with B. pseudomallei strain 1026b (300 or 750 colony-forming units [CFU]/50 µL 0.9% NaCl) as previously described (23) (24) (25) (26) . These doses represent an approximate 65% and 100% lethal dose, respectively. For survival experiments, mice were checked every 4-6 hours until death occurred or until a maximum of 15 days. Sample harvesting and processing and determination of bacterial growth were performed as described (23) (24) (25) (26) . For details, see the online supplement (Supplemental Digital Content 1, http://links. lww.com/CCM/A824).
Assays
Lung homogenates were diluted in lysis buffer, sterilized, and stored at -20°C until analysis. Citrated blood was centrifuged at 664 × g, and plasma was snap frozen at -80°C. Before storage, all samples were filtered through a 22-µm filter (Millipore, Billerica, MA). Assays for cytokines, chemokines, thrombin-antithrombin complexes (TATc), plasminogen activator inhibitor 1 (PAI-1), tissue-type plasminogen activator (tPA), Western blotting on fibrin degradation products, lactate dehydrogenase (LDH), aspartate aminotransferase (ASAT), alanine aminotransferase (ALAT), both markers for www.ccmjournal.org e223 hepatocellular injury and urea, and a marker for renal failure are described in the online supplement (Supplemental Digital Content 1, http://links.lww.com/CCM/A824), as are methods for Western blots, cell counts, and flow cytometry.
Histology and Immunohistology
Paraffin-embedded 4-µm tissue sections were stained with hematoxylin and eosin and analyzed for inflammation and tissue damage as described (23) (24) (25) (26) . Granulocyte stainings using fluorescein isothiocyanate-labeled rat-anti-mouse Ly-6G mAb (BD Pharmingen, San Diego, CA) were performed. For details, see the online supplement (Supplemental Digital Content 1, http://links.lww.com/CCM/A824).
Statistical Analysis
Data are expressed as box and whisker plots showing the smallest observation, lower quartile, median, upper quartile, and largest observation or as medians with interquartile ranges. All variables were rank-transformed prior to analysis. Comparisons between groups were conducted using overall nonparametric analysis of variance with modeled effects for strain, time, and their interaction (if appropriate), followed by post hoc Mann-Whitney U tests at the individual time points. For survival studies, Kaplan-Meier analyses followed by log-rank test were performed. All analyses were done using SPSS (SPSS, version 18, Armonk, NY). p values of less than 0.05 were considered statistically significant.
RESULTS
Lack of the Lectin-Like Domain of TM Is Associated With Reduced Gram-Negative Bacterial Growth and Dissemination
Our model of lung sepsis is associated with marked bacterial proliferation in the lungs, as well as in the blood, spleen, and liver (23) (24) (25) (26) . In order to establish whether the lectin-like domain of TM affects bacterial growth and dissemination, WT and TM LeD/LeD mice were infected with 750 CFU of B. pseudomallei and killed after 24, 48, and 72 hours to determine bacterial loads in lungs (the primary site of infection), liver, spleen, and blood. At 48 hours, TM LeD/LeD mice had lower bacterial loads in the lungs and liver (both p < 0.05) ( Fig. 1, A and C) , whereas after 72 hours, bacterial loads were lower in all TM LeD/LeD organs, as compared with those from WT mice (p < 0.01 for lung, Fig. 1A ; p < 0.01 for blood, liver, and spleen, Fig. 1, B and D) . These data demonstrate that the lectin-like domain of TM plays a role in overcoming antibacterial defense mechanisms during Gram-negative lung sepsis.
TM LeD/LeD and WT Mice Exhibit Similar Lung Histopathology and Pulmonary Neutrophil Recruitment
Our murine model of melioidosis is associated with severe lung damage (23-26) and both WT and TM LeD/LeD mice infected with B. pseudomallei displayed inflammatory infiltrates in the lungs (Fig. 2 ). There were, however, no significant differences in lung inflammation between WT and TM LeD/LeD mice (Fig. 2, A-C) . We additionally analyzed neutrophil recruitment to lung tissue, as it is known that neutrophils play an important role in the host defense during melioidosis (19, 27) . Immunostaining of histologic sections for Ly-6G revealed neutrophil infiltrates in the lungs of WT and TM LeD/LeD mice that increased over time during the course of the infection. However, there were no significant differences in Ly-6G staining between WT and TM LeD/LeD mice (Fig. 2,  D-F) . Accordingly, levels of myeloperoxidase, a marker for total neutrophil content, in lung homogenates were also similar in WT and TM LeD/LeD mice ( Fig. 2G) .
TM LeD/LeD Mice Have Lower Cytokine Levels in Lungs After Infection With B. pseudomallei
Infection with B. pseudomallei is associated with a prominent inflammatory response with elevations in cytokines (19, 27) .
We measured levels of tumor necrosis factor(TNF)-α, interleukin (IL)-6, IL-12p70, interferon (IFN)-γ, and monocyte chemoattractant protein (MCP)-1 in lung homogenates at various times following infection ( Table 1) . Although we could not detect differences in cytokine levels at 24 hours, there was a time-dependent progressive difference at 48 and 72 hours. Thus, 48 hours post infection, IL-6, IFN-γ, and MCP-1 were significantly lower in lung homogenates of TM LeD/LeD mice compared with WT mice (p < 0.01, 0.001, and 0.01, respectively). At 72 hours, TNF-α, IL-12p70, IL-6, IFN-γ, and MCP-1 were lower in TM LeD/LeD mice (p < 0.01, 0.001, 0.01, 0,001, and 0.01, respectively).
Lack of the Lectin-Like Domain of TM Is Associated With a Less Severe Proinflammatory Response in Bronchoalveolar Lavage Fluid
Pneumonia may lead to alveolar damage and subsequent alveolar leakage and release of proinflammatory factors (28) . We, therefore, assessed the role of the TM lectin-like domain on CFU and inflammatory cytokines in bronchoalveolar lavage fluid (BALF) 72 hours post inoculation when bacterial growth ( Fig. 1 ) and lung homogenate cytokine levels (Table 1) were most elevated. As shown in Figure 3 , TM LeD/LeD mice had significantly lower bacterial loads in BALF as compared with WT mice (p < 0.001) (Fig. 3A) . This was associated with lower total protein and total cell counts in BALF (p < 0.05 and < 0.001, respectively, for the difference between WT and TM LeD/LeD mice) ( Fig. 3, B and C) . The reduced number of cells was mainly due to fewer neutrophils and a decreased amount of macrophages in BALF of TM LeD/LeD mice when compared with WT mice (both p < 0.001) ( Fig. 3, D and E) . Since TM may interact with components of the complement system (5, 6), we also measured C3a and C5a levels in BALF. C3a levels were significantly lower in the BALF of TM LeD/LeD mice as compared with WT mice (p < 0.01) ( Fig. 3F) . In contrast, BALF C5a levels were not detectably different (data not shown). The lectin-like domain of TM also reportedly binds to HMGB1 (9) and prevents the latter's interaction with the receptor for advanced glycation endproducts (RAGE), thereby dampening HMGB1's proinflammatory effects (9) . We, therefore, semiquantitatively measured HMGB1 levels in BALF of WT and TM LeD/LeD mice by Western blot. Although BALF levels of HMGB1 in uninfected WT and TM LeD/LeD mice were similar ( Fig. 3G) , HMGB1 levels in infected TM LeD/LeD mice were significantly lower when compared with WT mice (p < 0.05) (Fig. 3, G and H) .
TM LeD/LeD Mice Exhibit Reduced Systemic Coagulation Activation After Infection With B. pseudomallei
We have previously shown that murine melioidosis is associated with inflammation and coagulation activation, which is most evident at later time points, such as after 48 and 72 hours of infection (23) (24) (25) . Although the lectin-like domain of TM is not known to directly regulate coagulation or fibrinolysis (2, 11) , we considered whether lack of the lectin-like domain of TM would influence coagulation and fibrinolysis in our model of murine melioidosis. Levels of TATc, a marker of coagulation activation, were similar in the lung homogenates of WT and TM LeD/LeD mice 48 and 72 hours post infection ( Fig. 4A) . At the same time, however, in plasma TATc levels were significantly lower in TM LeD/LeD mice (p < 0.05) ( Fig. 4B ), suggesting lower generation of thrombin in these mice. Levels of PAI-1 did not differ between both groups at any of the time points ( Fig.  4C) , whereas, surprisingly, levels of tPA were increased in TM LeD/LeD mice in comparison with WT mice, 48 hours after infection (p < 0.01; Fig. 4D ). Finally, levels of fibrin degradation products (including fragment X and d-dimer) were not significantly different between WT and TM LeD/LeD mice ( Fig. 4 E-H) at any of the time points, indicating that activation of fibrinolysis was equal in both groups.
Lack of the Lectin-Like Domain of TM Is Associated With Attenuated Systemic Inflammation and Organ Injury
Since TM LeD/LeD mice respond to the Gram-negative infection with less bacterial dissemination to blood, liver, and spleen, we considered whether this would result in attenuated systemic inflammation and organ injury. Indeed, at 72 hours after infection, significantly decreased levels of proinflammatory cytokines were measured in plasma of TM LeD/LeD mice in comparison with WT mice; at 24 and 48 hours, no differences between groups were detected ( Table 2) . Furthermore, at 72 hours post infection, plasma levels of LDH, urea, ASAT, and ALAT were all significantly elevated in WT mice ( Fig. 5A-D) .
In striking contrast, at 72 hours, mice lacking the TM lectin-like domain had minimally elevated levels of these markers of tissue damage, and all were significantly lower compared with WT mice (p < 0.01 for LDH, urea, ASAT, and ALAT) ( Fig. 5A-D) . In addition, histopathological scores of damage and inflammation of spleens were lower in infected TM LeD/LeD mice when compared with WT mice, 72 hours after inoculation (p < 0.01) ( Fig. 5E-G) . Altogether, these data indicate that in response to infection with B. pseudomallei, systemic proinflammatory cytokine levels are dampened and protection from tissue damage is afforded when the lectin-like domain of TM is lacking.
TM LeD/LeD Mice Display a Survival Advantage During Murine Melioidosis
To determine the impact of the lectin-like domain of TM during severe Gram-negative lung sepsis caused by B. pseudomallei, we infected WT mice with 750 CFU B. pseudomallei (i.e., the dose used in the experiments described above) and performed a survival study. Whereas all WT mice died, two of 16 TM LeD/LeD mice (13%) survived (p = 0.2) ( Fig. 6A) . Arguing that this dose might have been too overwhelming to detect a significant difference between the groups, we inoculated mice with a lower (300 CFU) dose of B. pseudomallei and found a decreased mortality of TM LeD/LeD mice when compared with WT mice: five of 15 WT mice (33%) survived versus 11 of 13 TM LeD/LeD mice (85%) (p < 0.01) (Fig. 6B) . These results indicate that lack of the lectin-like domain of TM is important for protection against mortality in this model.
DISCUSSION
TM is a multidomain transmembrane glycoprotein involved in multiple physiologically important anti-inflammatory, anticoagulant, and antifibrinolytic mechanisms (2, 29) . Although the function of the lectin-like domain of TM has been studied in models of sterile inflammation (6-8, 11, 13, 14) and Gram-positive infection (17) , the role of this TM domain in Gram-negative infection has hitherto not been reported.
The lectin-like domain of TM has been implicated as an important mediator of inflammation in several in vivo models (11) . After intraperitoneal challenge with LPS, TM LeD/LeD mice displayed reduced survival, accumulation of more neutrophils in their lungs, and greater elevation of serum cytokine levels (11) . TM LeD/LeD mice also exhibited a more severe phenotype in comparison with WT mice in response to experimentally induced murine arthritis (6), ischemia-reperfusion lung injury (13) , shiga toxin-associated HUS (14) , and diabetic glomerulopathy (15) . In contrast, our laboratory recently reported that TM LeD/LeD mice have improved survival and diminished bacterial growth and dissemination during Gram-positive pneumonia caused by S. pneumoniae (17) . Interestingly, administration of recombinant soluble TM lectin-like domain resulted in enhanced bacterial clearance and dramatically improved survival after intraperitoneal infection with the Gram-negative pathogen K. pneumoniae (7) . Soluble TM lectin-like domain at least in part acts as a decoy receptor, which could explain similar beneficial effects of administration of recombinant soluble lectin-like domain during Klebsiella sepsis (7) and of deficiency of the TM lectin-like domain as described here. One possible mechanism by which the (soluble) TM lectin-like domain could influence host defense during Gram-negative infection is by interacting with LPS (7) . One could speculate that in the case of a gradually expanding bacterial burden at the primary site of infection, such as in the current model, the diminished inhibition of LPS due to the absence of the TM lectin-like domain might result in a attenuated early innate immune response to Gram-negative infection (30) . On the other hand, during late-stage infection, uncontrolled LPS activity might exaggerate tissue injury. We here show that such a damaging effect of an absent TM lectin-like domain does not occur during lethal Gram-negative lung sepsis, that is, there was minimal evidence of tissue injury in the TM LeD/LeD mice, presumably due to the much lower bacterial loads. Future research should establish whether S. pneumoniae and/ or B. pseudomallei directly interact with TM. HMGB1, released from necrotic cells or secreted from inflammatory cells after cytokine stimulation, is a potent proinflammatory mediator (31) , mediated by its binding to RAGE and/or Toll-like receptor 4 (9, 32, 33) . The lectin-like domain of TM is capable of sequestering HMGB1, thereby dampening the proinflammatory properties of HMGB1 (9) . We hypothesized that lack of the lectinlike domain would result in increased HMGB1 levels, which on one hand could exert antibacterial effects (34) and on the other hand could exaggerate collateral organ damage. However, HMGB1 levels in BALF of TM LeD/LeD mice were lower than those in BALF of WT mice, most likely as a consequence of the lower bacterial loads in the former group, inducing a less severe proinflammatory response.
The complement system is a major component of innate immunity by formation of cell-killing membrane attack complexes, which are formed upon activation of (among others) complement factors C3a, C3b, and C5b (35) . In previous studies, TM LeD/LeD mice were shown to exhibit enhanced complement activation that was manifest by increased C3 deposition when compared with WT mice (6, 14) . In diabetic TM LeD/LeD mice, glomerular C3 deposition was increased when compared with nondiabetic TM LeD/LeD mice and diabetic WT mice (15) . These observations were consistent with a role for the lectin-like domain of TM in dampening activation. In the model of experimentally induced arthritis, C3 deposition increased to such an extent that no differences could be measured between WT and TM LeD/LeD mice (6) , whereas in the model of shiga toxin-associated HUS, there was a slight, albeit, not statistically significant increase in C3 deposition (14) . In contrast, we demonstrated markedly decreased C3a levels in BALF of TM LeD/LeD mice infected with B. pseudomallei when compared with WT mice, presumably consistent with the overall dampened state of inflammation in these mice.
It remains to be established whether the previously described basal augmented complement activation in TM LeD/LeD mice (6, 11, 14) contributes to the attenuated growth of B. pseudomallei in these animals, resulting in lower bacterial loads and as a consequence thereof diminished inflammation and mortality. Thus far, only limited data exist on the role of complement in the host defense against B. pseudomallei (20, 36) .
Neutrophils play an important role in host defense against B. pseudomallei infection (20, 27) . TM LeD/LeD mice displayed increased neutrophil recruitment to lungs upon LPS nebulization (11) and during ischemia/reperfusion-induced lung injury (13) . In theory, enhanced neutrophil influx to the primary site of infection could have resulted in an improved antibacterial defense during experimental melioidosis. However, lung neutrophil counts were similar between TM LeD/LeD and WT mice at all time points.
In contrast to the TM EGF-rich domain, which is responsible for PC and TAFI activation (10), the lectin-like domain of TM does not affect activation of procoagulant or anticoagulant factors (11) . TM LeD/LeD mice have unaltered plasma levels of PC and APC, even after intraperitoneal LPS challenge (11) , indicating that deficiency of the lectin-like domain of TM does not influence inflammation-induced coagulation activation. In accordance, we found similarly enhanced pulmonary coagulation activation, as reflected by lung TATc levels, in TM LeD/LeD and WT mice (11) . Plasma TATc levels, however, were lower in TM LeD/ LeD mice when compared with WT mice at 72 hours post infection. This may be a reflection of the decreased bacterial loads and, consequently, the less severe proinflammatory response in the TM LeD/LeD mice. Along the same line, during this late stage of infection, shortly before the first WT mice started to succumb, TM LeD/LeD mice had much lower plasma cytokine levels and less evidence of organ damage, as reflected by reduced plasma levels of urea, transaminases, and LDH, and supported histologically by less damage to the spleen. Altogether, the attenuated systemic inflammatory response and the mitigated multiple organ failure in TM LeD/LeD mice most likely played a major role in their reduced mortality. Notably, TM LeD/LeD mice demonstrated elevated lung tPA levels at 48 hours, whereas PAI-1 concentrations were similar to those measured in WT mice. The TM LeD/LeD mutation has not been reported to influence fibrinolysis. In accordance, TM LeD/LeD mice did not show altered levels of fibrin degradation products in their lungs, indicating that overall fibrinolytic activity was not altered in these animals. Further research is warranted to obtain insight into the possible indirect effects of the TM LeD/LeD mutation on tPA release and fibrinolysis during severe infection.
In conclusion, we have shown that mice lacking the lectin-like domain of TM are protected against Gram-negative lung sepsis caused by B. pseudomallei and that this is associated with inhibition of bacterial growth, reduced release of proinflammatory cytokines, and ultimately by inhibition of multiple organ failure. Recent clinical studies provided preliminary evidence that administration of full-length soluble TM may be of benefit to patients with severe sepsis (37, 38) . Although the present results cannot be extrapolated easily to human sepsis, our findings provide novel insights into the mechanisms that regulate the inflammatory response to Gram-negative infection.
